Mucus Removal Before Embryo Transfer
Launched by FUNDACION DEXEUS · Sep 21, 2017
Trial Information
Current as of May 29, 2025
Completed
Keywords
ClinConnect Summary
ET involves placing the embryo(s) obtained before assisted reproduction technology (ART) into the uterus via a catheter advanced through the cervical canal. Yet this is the final, and in some respects the most critical, process in the sequential events that encompass an ART cycle. If an embryo cannot be delivered to the uterine cavity atraumatically and in a location for optimal implantation, the steps of ovarian hyperstimulation, oocyte retrieval, embryo culture, and embryo selection will have no benefit. Contamination of the catheter with blood may be a marker for difficult ET and has als...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • IVF or OD patients with supernumerary embryos (oocyte's age will be considered as patient's age).
- • Normal transvaginal ultrasound at screening, without evidence of clinically significant abnormality consistent with finding adequate for ART with respect to uterus and adnexa
- • Single embryo transfer
- • Embryo transfer at the blastocyst stage
- • Embryo with a morphological classification of ≥3BB
- Exclusion Criteria:
- • Preimplantation genetic diagnosis and/or screening
About Fundacion Dexeus
Fundación Dexeus is a prominent clinical trial sponsor dedicated to advancing medical research and improving patient outcomes through innovative healthcare solutions. Based in Barcelona, Spain, the organization focuses on a wide range of therapeutic areas, particularly in women's health, reproductive medicine, and fertility. With a commitment to ethical practices and rigorous scientific methodologies, Fundación Dexeus collaborates with leading medical professionals and research institutions to conduct high-quality clinical trials. Their mission is to generate valuable data that informs clinical practices, enhances treatment options, and ultimately contributes to the betterment of healthcare globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Barcelona, , Spain
Patients applied
Trial Officials
Jorge Rodriguez-Purata, MD
Principal Investigator
Hospital Universitario Dexeus
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials